The Center for Clinical Epidemiology and Outcomes Research - CLEO (https://www.cleoresearch.org) was given the Gold award in the category for Patient Safety for the National Program for the Prevention and Control of Hospital Acquired Infections and Antimicrobial Resistance, "Greek Infection Prevention Program, GRIPP-SNF", at the Patient Partnerships Awards 2022 (https://www.patientawards.gr/) organized by Health Daily of BOUSSIAS Communications.
Written by Dimitra Kousi, Junior Biostatistician, CLEO.
What is the microbiome?
Trillions of microorganisms colonize our gastrointestinal tract, skin, genito-urinary system etc., together forming the ‘human microbiome’. Most of these microorganisms are bacteria, but the microbiome also includes fungi, protozoa and viruses. Some of these microorganisms have a beneficial effect on our health, others have been associated with harmful functions while others remain neutral.
Recent studies on the human microbiome showed that 56% of the total cell count in our body are not human cells, but bacterial, weighing nearly 0,2 kg (almost as much as a zucchini!) (1). The microbiome is unique for each and every one of us and, in a way, constitutes our identity (2). The vast majority of the human microbial communities inhabit the gastrointestinal tract, and this is the reason why the gut microbiome (GM) has attracted the most attention.
The COVID-19 pandemic has presented unique, unprecedented challenges for national healthcare systems. The faltering global response - characterized by a lack of preparedness among health care institutions, workers and the wider community - has underscored the importance
But to win the war against infectious disease – and to be ready for the next health crisis – we need a stronger, more accountable health system.
We should all be proud of our country’s successful response to the coronavirus crisis. It shows that with a concerted group effort from everyone in our society, we can achieve better health outcomes – better even than other countries with far more resources.
Center for Clinical Epidemiology and Outcomes Research (CLEO) was founded thanks to a grant from the Stavros Niarchos Foundation, which from 2011 until today continues to support its operation as a major donor.
This website uses Google Analytics cookies. Those cookies collect statistical information on how you navigate on our webpage. For example we track most visited pages of our website, link references and the timestamp. We use this information to improve our content, to increase performance and reduce compatibility issues.
You have declined cookies. This decision can be reversed.
You have allowed cookies to be placed on your computer. This decision can be reversed.
Cookie Consent - EU e-Privacy Directive
This website uses Google Analytics cookies. Those cookies collect statistical information on how you navigate on our webpage. For example we track most visited pages of our website, link references and the timestamp. We use this information to improve our content, to increase performance and reduce compatibility issues.